- Home
- MCRB vs LAKE Comparison
MCRB vs LAKE Comparison
Compare MCRB & LAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- LAKE
- Stock Information
- Founded
- MCRB 2010
- LAKE 1982
- Country
- MCRB United States
- LAKE United States
- Employees
- MCRB N/A
- LAKE N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- LAKE Industrial Specialties
- Sector
- MCRB Health Care
- LAKE Health Care
- Exchange
- MCRB Nasdaq
- LAKE Nasdaq
- Market Cap
- MCRB 131.0M
- LAKE 144.9M
- IPO Year
- MCRB 2015
- LAKE 1986
- Fundamental
- Price
- MCRB $0.73
- LAKE $25.94
- Analyst Decision
- MCRB Buy
- LAKE Strong Buy
- Analyst Count
- MCRB 4
- LAKE 2
- Target Price
- MCRB $5.63
- LAKE $27.50
- AVG Volume (30 Days)
- MCRB 2.0M
- LAKE 50.6K
- Earning Date
- MCRB 03-04-2025
- LAKE 12-05-2024
- Dividend Yield
- MCRB N/A
- LAKE 0.44%
- EPS Growth
- MCRB N/A
- LAKE N/A
- EPS
- MCRB N/A
- LAKE N/A
- Revenue
- MCRB $126,325,000.00
- LAKE $151,822,000.00
- Revenue This Year
- MCRB N/A
- LAKE $37.18
- Revenue Next Year
- MCRB N/A
- LAKE $22.27
- P/E Ratio
- MCRB N/A
- LAKE N/A
- Revenue Growth
- MCRB 12856.41
- LAKE 23.99
- 52 Week Low
- MCRB $0.54
- LAKE $15.10
- 52 Week High
- MCRB $1.53
- LAKE $27.28
- Technical
- Relative Strength Index (RSI)
- MCRB 37.88
- LAKE 61.63
- Support Level
- MCRB $0.71
- LAKE $25.60
- Resistance Level
- MCRB $0.91
- LAKE $26.64
- Average True Range (ATR)
- MCRB 0.06
- LAKE 1.03
- MACD
- MCRB -0.02
- LAKE -0.04
- Stochastic Oscillator
- MCRB 8.37
- LAKE 56.35
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.